Based on these findings, therapeutic strategies targeting macrophages, such as inhibiting the CCR2 pathway to reduce macrophage recruitment, may help alleviate vascular remodeling and the pathological responses associated with hypertension [36,71]. This evidence concerns the gene CCR2 and Hypertension.